| Autor: |
Baldassarre, Lucila, Quach-Thanh, Caroline, Mouajou Feujio, Verinsa, Tadount, Fazia, Deyirmendjian, Claudia, Lefebvre, Marie-Astrid, Thampi, Nisha, Schneider, Oliver, Fabri-Karam, Isabela, O’Donnell, Shauna, Okeny-Owere, James, Audy, N., Desmarais, Nadia |
| Zdroj: |
Infection Control & Hospital Epidemiology; February 2024, Vol. 45 Issue: 2 p182-187, 6p |
| Abstrakt: |
AbstractObjectives:Incidence and risk factors for recurrent Clostridioides difficileinfection (rCDI) are well established in adults, though data are lacking in pediatrics. We aimed to determine incidence of and risk factors for rCDI in pediatrics.Methods:This retrospective cohort study of pediatric patients was conducted at 3 tertiary-care hospitals in Canada with laboratory-confirmed CDI between April 1, 2012, and March 31, 2017. rCDI was defined as an episode of CDI occurring 8 weeks or less from diagnostic test date of the primary episode. We used logistic regression to determine and quantify risk factors significantly associated with rCDI.Results:In total, 286 patients were included in this study. The incidence proportion for rCDI was 12.9%. Among hospitalized patients, the incidence rate was estimated at 2.6 cases of rCDI per 1,000 hospital days at risk (95% confidence interval [CI], 1.7–3.9). Immunocompromised patients had higher incidence of rCDI (17.5%; P= .03) and higher odds of developing rCDI independently of antibiotic treatment given for the primary episode (odds ratio [OR], 2.31; 95% CI, 1.12–5.09). Treatment with vancomycin monotherapy did not show statistically significant protection from rCDI, independently of immunocompromised status (OR, 0.33; 95% CI, 0.05–1.15]).Conclusions:The identification of increased risk of rCDI in immunocompromised pediatric patients warrants further research into alternative therapies, prophylaxis, and prevention strategies to prevent recurrent disease burden within these groups. Treatment of the initial episode with vancomycin did not show statistically significant protection from rCDI. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
